Alla Verlinsky

1.3k total citations
9 papers, 360 citations indexed

About

Alla Verlinsky is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Alla Verlinsky has authored 9 papers receiving a total of 360 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Molecular Biology and 2 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Alla Verlinsky's work include Cancer Research and Treatments (2 papers), Cell Adhesion Molecules Research (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). Alla Verlinsky is often cited by papers focused on Cancer Research and Treatments (2 papers), Cell Adhesion Molecules Research (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). Alla Verlinsky collaborates with scholars based in United States and Japan. Alla Verlinsky's co-authors include Marcus P. Cooper, Hidekazu Tsukamoto, Cheng Ji, Aurelia Lugea, Jun Xu, Samuel W. French, Keane K. Y. Lai, David R. Stover, Pia M. Challita-Eid and Zili An and has published in prestigious journals such as PLoS ONE, Cancer Research and Journal of Hepatology.

In The Last Decade

Alla Verlinsky

9 papers receiving 357 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alla Verlinsky United States 7 135 114 102 79 59 9 360
Daniela Martinetti Italy 10 132 1.0× 101 0.9× 47 0.5× 35 0.4× 41 0.7× 11 350
Dawn Q. Chong Singapore 10 141 1.0× 115 1.0× 191 1.9× 42 0.5× 49 0.8× 21 471
Viola Baradari Germany 7 257 1.9× 202 1.8× 102 1.0× 97 1.2× 88 1.5× 9 507
Hiroaki Hagihara Japan 13 144 1.1× 72 0.6× 159 1.6× 64 0.8× 32 0.5× 25 427
Bangbo Zhao China 14 205 1.5× 147 1.3× 61 0.6× 25 0.3× 90 1.5× 43 435
Hiroki Teraoku Japan 13 116 0.9× 107 0.9× 46 0.5× 37 0.5× 96 1.6× 44 352
Seok-Hyun Kim South Korea 8 250 1.9× 191 1.7× 61 0.6× 59 0.7× 36 0.6× 16 447
Masuo Tokoo Japan 9 119 0.9× 194 1.7× 82 0.8× 50 0.6× 104 1.8× 16 339
Hiroaki Shima Japan 10 102 0.8× 149 1.3× 39 0.4× 33 0.4× 78 1.3× 36 336
Dorota Lemancewicz Poland 10 123 0.9× 98 0.9× 38 0.4× 26 0.3× 34 0.6× 34 327

Countries citing papers authored by Alla Verlinsky

Since Specialization
Citations

This map shows the geographic impact of Alla Verlinsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alla Verlinsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alla Verlinsky more than expected).

Fields of papers citing papers by Alla Verlinsky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alla Verlinsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alla Verlinsky. The network helps show where Alla Verlinsky may publish in the future.

Co-authorship network of co-authors of Alla Verlinsky

This figure shows the co-authorship network connecting the top 25 collaborators of Alla Verlinsky. A scholar is included among the top collaborators of Alla Verlinsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alla Verlinsky. Alla Verlinsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Caenepeel, Sean, Brian Belmontes, Alla Verlinsky, et al.. (2020). Abstract 6218: Discovery and preclinical evaluation of AMG 397, a potent, selective and orally bioavailable MCL1 inhibitor. Cancer Research. 80(16_Supplement). 6218–6218. 33 indexed citations
2.
Joh, Nathan H., Lisa Thomas, Alla Verlinsky, et al.. (2019). Silicone Oil Particles in Prefilled Syringes With Human Monoclonal Antibody, Representative of Real-World Drug Products, Did Not Increase Immunogenicity in In Vivo and In Vitro Model Systems. Journal of Pharmaceutical Sciences. 109(1). 845–853. 25 indexed citations
3.
Morrison, Kendall, Pia M. Challita-Eid, Arthur Raitano, et al.. (2016). Development of ASG-15ME, a Novel Antibody–Drug Conjugate Targeting SLITRK6 , a New Urothelial Cancer Biomarker. Molecular Cancer Therapeutics. 15(6). 1301–1310. 55 indexed citations
4.
Campbell, Dean O., Akihiro Noda, Alla Verlinsky, et al.. (2016). Preclinical Evaluation of an Anti-Nectin-4 ImmunoPET Reagent in Tumor-Bearing Mice and Biodistribution Studies in Cynomolgus Monkeys. Molecular Imaging and Biology. 18(5). 768–775. 25 indexed citations
5.
Rudra-Ganguly, Nandini, Michael Mattie, Mi Sook Chang, et al.. (2014). Discoidin Domain Receptor 1 Contributes to Tumorigenesis through Modulation of TGFBI Expression. PLoS ONE. 9(11). e111515–e111515. 23 indexed citations
6.
Rudra-Ganguly, Nandini, Claudia Guevara, Christopher C. Kemball, et al.. (2014). Abstract 1976: MDR expression/ activity may serve as potential biomarker in developing therapeutic drugs for AML therapy. Cancer Research. 74(19_Supplement). 1976–1976. 1 indexed citations
7.
Mattie, Mike, Ashley Christensen, Mi Sook Chang, et al.. (2013). Molecular Characterization of Patient-Derived Human Pancreatic Tumor Xenograft Models for Preclinical and Translational Development of Cancer Therapeutics. Neoplasia. 15(10). 1138–IN17. 74 indexed citations
8.
Mattie, Michael, Mi Sook Chang, Ashley Christensen, et al.. (2012). Abstract 1314: Molecular profiling and characterization of patient-derived human pancreatic tumor xenograft models, and application for drug discovery and preclinical development of cancer therapeutics. Cancer Research. 72(8_Supplement). 1314–1314. 1 indexed citations
9.
Xu, Jun, Keane K. Y. Lai, Alla Verlinsky, et al.. (2011). Synergistic steatohepatitis by moderate obesity and alcohol in mice despite increased adiponectin and p-AMPK. Journal of Hepatology. 55(3). 673–682. 123 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026